Gina Jiang
Managing Director, Hong Kong Institute of Biotechnology
Gina Jiang is listed as Managing Director, Hong Kong Institute of Biotechnology. Gina is scheduled to speak at Advanced Therapies Week 2027 on 20 January 2027.
Compiled from published conference agendas; not yet confirmed by Gina. Is this you? Claim this profile.
About
Dr. Gina Jiang is a physician-scientist, biomanufacturing leader, and MedTech entrepreneur bridging clinical rigor, emerging tech, and regulatory execution. Educated and trained at the University of Toronto, Peking University, Stanford, and the NIH, she brings deep multi-disciplinary expertise to cellular therapeutics. As Managing Director of the Hong Kong Institute of Biotechnology (HKIB), Dr. Jiang established Hong Kong’s first PIC/S GMP-certified Advanced Therapy Products facility—enabling clinical-grade CAR-T releases for trials. Her core strength lies in translating lab breakthroughs into compliant delivery to make life-saving therapeutics safer, faster, and globally accessible.
Upcoming
Advanced Therapies Week 2027 19 January 2027 – 21 January 2027
- Plenary: Plotting a course to sustainable future success for the cell & gene therapy industry Speaker · 20 January 2027
- Roundtable discussion: The global picture Speaker · 20 January 2027
- Fireside Chat: How to manufacture your biologics in China? Navigating the uncertainties Speaker · 21 January 2027
- Session 8: How is the advanced therapies manufacturing and supply chain infrastructure evolving worldwide in support of global clinical development opportunities Speaker · 21 January 2027
Spoke alongside
People who have shared a session with Gina at events on B2DB.
- Peter He Co-Founder & Chief Scientific Officer · OriCell Therapeutics 2 shared sessions
- Samar Mohanty President & CSO · Nanoscope Therapeutics 2 shared sessions
- Sven Kili Partner · Saisei Ventures 1 shared session
- Cédric Cleyrat Executive Director, Head of Cell Therapy BioEngineering & Technology Innovation · Bristol Myers Squibb 1 shared session
- Kelsey Wakley-Sharman Director of Operations - Cell & Gene Therapies · QuickSTAT 1 shared session
- Nelly Viseux VP Cell Therapies Development, Manufacturing Supply & Quality · Regeneron Pharmaceuticals 1 shared session
- Steven Oh Director, Office of Cellular Therapy and Human Tissue, Office of Therapeutic Products, CBER · US Food & Drug Administration 1 shared session
- Yoshiaki Maruyama Director, Office of Cellular and Tissue-based Products · Pharmaceuticals and Medical Devices Agency (PMDA), Japan 1 shared session